98 related articles for article (PubMed ID: 317079)
1. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
Feltham S; Ronald AR; Albritton WL
J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
[No Abstract] [Full Text] [Related]
2. In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.
Biddle JW; Thornsberry C
Antimicrob Agents Chemother; 1979 Feb; 15(2):243-5. PubMed ID: 106776
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Santoro J; Kaye D; Levison ME
Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
Aldridge KE; Cammarata C; Martin DH
Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
[TBL] [Abstract][Full Text] [Related]
5. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
Kwok YY; Sutter VL; Oberhammer I; Finegold SM
J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
[No Abstract] [Full Text] [Related]
6. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the in vitro activity of rosamicin, erythromycin, spiramycin, penicillin and tetracycline against N. gonorrhoeae, including beta-lactamase producing isolates.
Dillon JR; Duck PD; Eidus L
J Antimicrob Chemother; 1978 Sep; 4(5):477-80. PubMed ID: 99424
[No Abstract] [Full Text] [Related]
8. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
[TBL] [Abstract][Full Text] [Related]
9. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Shadomy S; Tipple M; Paxton L
Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
[TBL] [Abstract][Full Text] [Related]
10. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
[TBL] [Abstract][Full Text] [Related]
11. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Madinier IM; Fosse TB; Hitzig C; Charbit Y; Hannoun LR
J Periodontol; 1999 Aug; 70(8):888-92. PubMed ID: 10476896
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.
Levison ME; Santoro J; Bran JL; Ries K; Rubin W
J Infect Dis; 1977 Mar; 135 Suppl():S49-53. PubMed ID: 850091
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Haemophilus ducreyi. A study.
Sng EH; Lim AL; Rajan VS; Goh AJ
Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
Sturm AW
J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
DiPersio JR; Krafczyk TL
Antimicrob Agents Chemother; 1978 Aug; 14(2):274-6. PubMed ID: 697353
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Haemophilus ducreyi.
Hammond GW; Lian CJ; Wilt JC; Ronald AR
Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
Lagergård T; Frisk A; Trollfors B
J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
